Achiko Logo cropped.jpg
Achiko AG – Investor Briefing
07 juil. 2022 15h22 HE | Achiko AG
ZURICH, Switzerland, July 07, 2022 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF, SIX: ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), would like to invite investors and shareholders to a...
22157.jpg
Global COVID-19 Rapid Test Kits Market Report 2022: Market is Expected to Decline from $19,547.5 Million in 2020 to $32.2 Million in 2025 at a Rate of -72.2%
18 mars 2022 07h28 HE | Research and Markets
Dublin, March 18, 2022 (GLOBE NEWSWIRE) -- The "COVID-19 Rapid Test Kits Global Market Opportunities And Strategies To 2030, By Test Type, Kit Type, Specimen Type, End Users" report has been added...
Achiko Logo cropped.jpg
Achiko AG Production and Sales Update
03 mars 2022 07h30 HE | Achiko AG
Unique Chemistry with DNA Aptamers Completing Pre-Sales Validation TestingCompleting Pre-Sales Validation Testing in Indonesia ZURICH, Switzerland, March 03, 2022 (GLOBE NEWSWIRE) -- Ad...
Global COVID-19 Diagnostics Market Report 2022: Market Size is Expected to Reach $283.93 Billion by 2029
17 févr. 2022 06h08 HE | Research and Markets
Dublin, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The "COVID-19 Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Mode; By Product & Service Type; By Sample Type; By Test Type; By End...
Achiko Logo cropped.jpg
Achiko AG Research Paper and Commercialization Update
14 févr. 2022 07h30 HE | Achiko AG
Calibration study results now available in draft paper on medRxiv, a preprint platform for health sciences, as “DNA Aptamer Gold Nanoparticle Colorimetric Diagnostic Test Kit of Saliva Samples for...
Achiko Logo cropped.jpg
Achiko AG Strengthens Senior Team with Appointment of Head of Corporate Development
27 janv. 2022 07h30 HE | Achiko AG
Achiko AG appoints David Hodge to the role of Head of Corporate Development in SwitzerlandDavid Hodge will oversee Corporate Affairs, and Strategic and Corporate DevelopmentBoard Director Christophe...
Achiko Logo cropped.jpg
Achiko AG Announces Feature Article on “How We Get Back to Normal” with its AptameX™ Covid-19 Rapid Test Technology
18 janv. 2022 07h30 HE | Achiko AG
ZURICH, Switzerland, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) is pleased to announce a feature article in The Jakarta Post:...
22157.jpg
Global COVID-19 Rapid Test Kits Markets Report 2021: Rapid Antigen, Rapid Antibody, Equipment and Extraction Kits, RT-PCR Test Kits, Reagents
09 déc. 2021 03h38 HE | Research and Markets
Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 Rapid Test Kits Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's...
Achiko Logo cropped.jpg
Achiko’s Covid-19 DNA Aptamer-Based Rapid Testing Platform Update
24 nov. 2021 07h30 HE | Achiko AG
Pilot program in Indonesia is on track with positive results and support for Achiko’s proprietary, low-cost rapid Covid-19 diagnostic test, AptameX, alongside its sister digital passporting service...
Logo.jpg
ProPhase Labs to Host Second Quarter 2021 Financial Results Conference Call on Friday, August 13, 2021 at 11:00 a.m. Eastern Time
09 août 2021 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY , Aug. 09, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Friday, August 13, 2021...